Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial [PDF]
van Anrooij, Bjorn +6 more
openaire +1 more source
Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis
Luis Escribano +5 more
doaj +1 more source
Symptom patterns before and after indolent systemic mastocytosis: A matched cohort analysis. [PDF]
Tse KY +13 more
europepmc +1 more source
Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study. [PDF]
Pongdee T +10 more
europepmc +1 more source
A rare manifestation of indolent systemic mastocytosis and its management during the coronavirus disease 2019 pandemic; educational lessons from Syria. [PDF]
Slaibi A +6 more
europepmc +1 more source
Denosumab as a Potential Disease-Modifying Treatment in Indolent Systemic Mastocytosis-Related Osteoporosis. [PDF]
Abbas M, Luthra P.
europepmc +1 more source
Cardiac Bypass Surgery in a Patient with an Indolent Systemic Mastocytosis [PDF]
Beckers, Stefan +7 more
openaire +3 more sources
SYSTEMIC MASTOCYTOSIS: CURRENT PROGRESS AND CHALLENGES
Mastocytosis refers to a group of rare disorders caused by the expansion and accumulation of clonal mast cells in various organs and tissues.1 Two main entities can be distinguished: cutaneous forms, typically occurring in childhood, and systemic forms ...
I. Tanasi
doaj
Indolent Systemic Mastocytosis Presenting with Consecutive Vertebral Fragility Fractures despite Normal Bone Mineral Density: A Case Report and Mechanistic Review. [PDF]
Barrientos RY +3 more
europepmc +1 more source

